Skip to main content

BDRX

Biodexa Pharmaceuticals Plc

Company with tickers: BDRX

CIK
1643918
CUSIP
59564R880
Shares Outstanding
746,114
13F Activity (30d)
4 filings 4 filers

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Holders: 7
Total Value: $228,007
Total Shares: 368,950

Institutional Ownership Trend

3 quarters

Holder Concentration

Across 7 13F filers · Δ vs Dec 31, 2025
Top Holder
69.8%
Sep 2025 → Mar 2026 · range 62.5% – 82.5%
+7.3 pts
Top 5
100.0%
Sep 2025 → Mar 2026 · range 99.9% – 100.0%
+0.0 pts
Top 10
100.0%
Sep 2025 → Mar 2026 · range 100.0% – 100.0%
0.0 pts
HHI
5,583
Sep 2025 → Mar 2026 · range 4,987 – 7,063
Highly concentrated+596

Quarterly Activity

vs Dec 31, 2025
New
1
Increased
2
Decreased
3
Sold Out
2
Unchanged
1
Holder count: -1
Institutional value: -67.1%
Shares held: +20.9%

Top Buyers

vs Dec 31, 2025
Institution Added Now Holds Open

Top Sellers

vs Dec 31, 2025
Institution Sold Now Holds Open

Top New Positions

vs Dec 31, 2025
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Dec 31, 2025
Institution Previously Held Last Value (USD) Open
Showing 7 of 7
Export CSV
Holder Value (USD) % of 13F Shares Open